1. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC, and Chada K (1995). Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82: 57–65.
2. Bandiera A, Bonifacio D, Manfioletti G, Mantovani F, Rustighi A, Zanconati F, Fusco A, Di Bonito L, and Giancotti V (1998). Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Res 58: 426–431.
3. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, and Fusco A (1995). Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 15: 1545–1553.
4. Bussemakers MJG, van de Ven WJM, Debruyne FMJ, and Schalken JA (1991). Identification of high mobility group protein I (Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res 51: 606–611.
5. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A, and Fusco A (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13: 2439–2446.